Keywords: taxotere, cleared, marketing, usa, rhone-poulenc, rorer, received

Taxotere Cleared For Marketing In USA

Article | 20 May 1996

Print This

Rhone-Poulenc Rorer has received clearance from the US Food and Drug Administration to market its anticancer drug Taxotere (docetaxel) as ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in